CAS: 159768-75-9: Lobradimil (RMP-7)

Xa kev nug
CAS: 159768-75-9: Lobradimil (RMP-7)
Paub meej
CAS: 159768-75-9 Nr
Cov qauv tseem ceeb: Kev xaiv zoo heev bradykinin B2 receptor agonist, ib qho kev sib piv ntawm bradykinin. Reversibly qhib cov ntshav-b hlwb barrier nruj junctions los ntawm activating B2 receptors ntawm cerebral vascular endothelium,
Nws txhim kho kev siv tshuaj intracerebral zoo nrog cov nyhuv me me ntawm cov ntshav siab.
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 99% purity, thov hu rau peb kom paub meej!
** Cov ntaub ntawv ntsig txog **
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Kev faib tawm yam khoom
Pharmaceutical Peptides
Share to
Hauj lwm lawm

Shanghai Sonyt Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov neeg muag khoom ntawm cas: 159768-75-9: lobradimil (rmp-7) hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo cas: 159768-75-9: lobradimil (rmp-7) los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe CAS: 159768-75-9: Lobradimil (RMP-7)
Kev piav qhia Lobradimil yog ib qho kev xaiv zoo heev bradykinin B2 receptor agonist. Nws tshwj xeeb khi rau B2 receptors ntawm cerebral microvascular endothelial hlwb, ib ntus thiab thim rov qab qhib nruj junctions ntawm cov ntshav- hlwb teeb meem, txhim kho intracerebral kev ua tau zoo ntawm cov tshuaj chemotherapeutic thiab macromolecules, nrog tsawg kawg nkaus ntawm cov ntshav siab. Hauv cov kab mob hauv nruab nrab ntawm cov paj hlwb xws li glioblastoma thiab lub hlwb metastasis, nws ua rau kom lub hlwb muaj zog thiab kho tau zoo ntawm co- tswj cov tshuaj antitumor. Nws yog ib qho cuab yeej classic peptide rau cov ntshav-b hlwb barrier tswj mechanism kev tshawb fawb thiab hlwb qog cov tshuaj xa mus tshawb fawb.
Peptide Purity (HPLC, %) 95% / 98% / 99%
Dawb puag molecular mis C₅₀H₇₃N₁₅O₁₁
Dawb puag molecular hnyav (Da) 1072.22, siab dua rau daim ntawv ntsev
Hom qauv Linear modified nonapeptide, bradykinin analog, dawb peptide / acetate ntsev

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv Product Abbreviation / Alias Function Tags (comma-sib cais) Core Structure Molecular Formula Exact Mass (Da) Qhov nruab nrab MW (Da) Daim ntawv ntsev Ntev (aa)
Lobradimil Lobradimil; RMP-7 Kev xaiv siab heev bradykinin B2 receptor agonist, thim rov qab cov ntshav - lub paj hlwb thaiv kev qhib, txhim kho lub hlwb xa tshuaj Bradykinin structural analog, linear hloov nonapeptide, xaiv khi rau B2 receptors ntawm cerebral vascular endothelium, ib ntus thiab reversibly qhib cov ntshav- lub hlwb barrier nruj junctions nrog tsawg kawg nkaus ntawm cov ntshav siab. Dawb peptide: C₅₀H₇₃N₁₅O₁₁ 1071.56 1072.22 Dawb peptide / acetate 9

Physicochemical Solubility & Cia Parameters

 

Khoom Code Qhov tshwm sim Ntev - Lub Sij Hawm Cia Luv - Lub Sij Hawm Cia Kev daws teeb meem Khoom hmoov ruaj khov
PEB-LOB001 hmoov dawb Khaws ntawm -20 degree, kaw, qhuav thiab tiv thaiv los ntawm lub teeb. Aliquot kom tsis txhob rov qab khov-thaw mus. ruaj khov rau 1 lub hlis ntawm 2-8℃nyob rau hauv kaw qhuav; nkoj ntawm cov pob khov nab kuab pom zoo. Nyob ruaj khov rau 14 hnub ntawm 4 degree. Dawb soluble hauv dej, dilute acetic acid thiab physiological buffers. Aqueous tov yog raug rau peptidase degradation; aliquot sterilely thiab khov tom qab reconstitution. ruaj khov rau 3 xyoos ntawm -20 degree, qhuav thiab tiv thaiv los ntawm lub teeb.

Functional Description

 

Khoom Code Frontend Short Summary (rau cov npe tshawb nrhiav) Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg Cov cheeb tsam tshawb fawb (comma- cais) Lub Hom Phiaj / Txoj Kev
PEB-LOB001 Selective B2 receptor agonist reversibly qhib cov ntshav -b hlwb barrier los txhim kho lub hlwb xa tshuaj Lobradimil (RMP-7) yog ib qho kev xaiv zoo heev ntawm bradykinin B2 receptor agonist. Nws tshwj xeeb khi rau B2 receptors ntawm cerebral microvascular endothelial hlwb, transiently thiab reversibly qhib nruj junctions ntawm cov ntshav- hlwb barrier, ho txhim khu intracerebral xa efficiency ntawm chemotherapeutic tshuaj, peptides thiab macromolecules, nrog tsawg kawg nkaus kev nyab xeeb ntawm cov ntshav siab. Hauv cov kab mob hauv nruab nrab ntawm cov paj hlwb xws li glioblastoma thiab lub hlwb metastasis, nws ua rau kom lub hlwb muaj zog thiab kho tau zoo ntawm co- tswj cov tshuaj antitumor. Nws yog ib qho cuab yeej classic peptide rau cov ntshav-hlwb thaiv kev tswj hwm kev tshawb fawb thiab kev tshawb fawb ntawm cov qog hlwb. Ntshav-Kev tshawb fawb txog kev tswj lub hlwb, kev tshawb fawb hauv hlwb qog nqaij hlav, kev tshawb fawb glioblastoma, kev tshawb fawb txog kev ua haujlwm ntawm bradykinin receptor, hauv nruab nrab paj hlwb kev loj hlob technology Bradykinin B2 receptor (BDKRB2); Ntshav-b hlwb barrier nruj hlws ris txoj cai txoj kev

 

 

 

 

 

 

 

 

 

Cim npe nrov: cas:159768-75-9: lobradimil (rmp-7), Tuam Tshoj cas:159768-75-9: lobradimil (rmp-7) manufacturers, lwm tus neeg, Hoobkas

Xa kev nug